The investigators are interested in learning more about choline, a nutrient required by the body. The body does make some choline, but it does not make enough to support health and the rest must be acquired through diet. Eggs, and especially egg yolks, are a major dietary source of choline. Choline can also be given as a dietary supplement. Ingestion of choline supplements has been linked to an increased concentration of a compound called TMAO (trimethylamine N-oxide). Elevated TMAO levels have been linked to higher heart disease risk. With this study, the investigators hope to learn whether there is a difference in the way your body responds to the ingestion of a choline supplement versus the choline found within eggs.
The principal goal for the study is to examine whether there is a difference between the ingestion of choline through supplements versus choline found within eggs on plasma TMAO levels. The investigators have previously shown that dietary intake of trimethylamines, including the choline group of phosphatidylcholine (PC), is mechanistically linked to cardiovascular disease risk and that the metabolism of these trimethylamine nutrients in humans is modulated by the intestinal microbes (gut microbes). Additionally, extensive animal studies link an essential role of gut microbiota to the metabolism of choline and the production of metabolites that promote / accelerate atherosclerotic processes. The investigators have also recently shown a 10-fold increase in plasma TMAO levels following supplementation with choline bitartrate supplements. However, another pilot study by a collaborator (unpublished) did not show the same increase in plasma TMAO levels following the ingestion of whole eggs, a major dietary source of choline. Therefore, with this study the investigators wish to examine the differences, if any, between the ingestion of an equivalent mass of total choline in the free form (as bitartrate salt) as a supplement vs. within whole eggs. Eggs, and specifically the egg yolk, contain a large amount of total choline. However, egg white contains potential anti-microbial peptides that could influence gut microbial composition and function, and therefore impact conversion of choline into TMA and TMAO observed in subjects. Therefore, the investigators hypothesize that the consumption of whole eggs (hardboiled) will not elevate plasma TMAO levels to the same extent as a comparable amount of total choline ingested in capsule form as the choline bitartrate salt. The investigators further hypothesize that the consumption of egg white with choline bitartrate tablets may result in less of a rise in TMAO levels than ingestion of the choline bitartrate supplement alone.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Enrollment
86
500mg choline bitartrate tablets
Obtained from a commercial source.
Egg whites from pre-cooked, pre-peeled hardboiled eggs. The yolks are removed and discarded.
420 mg phosphatidylcholine capsules obtained from a commercial source.
Cleveland Clinic Foundation
Cleveland, Ohio, United States
Changes in Plasma Levels of Fasting Trimethylamine-N-oxide (TMAO), a Choline Metabolite
Changes in levels of non-labeled TMAO from baseline to end-of-study (day 28) as measured by established techniques by mass spectrometry.
Time frame: Baseline, 28 days
Changes in Platelet Function With Increased Choline Intake
The activation and functioning of platelets within a single subject will be compared before and after increased choline intake.
Time frame: Baseline, Day 28
Changes in Levels of Fasting Trimethylamine-N-oxide (TMAO) in 24-hour Urine Collections
Changes in levels of non-labeled TMAO from baseline to Day 28 measured by established mass spectrometry techniques.
Time frame: Baseline, Day 28
Changes in Plasma Levels of Fasting Choline
Fasting plasma levels of choline from samples obtained at baseline and at day 28 were compared.
Time frame: Baseline, Day 28
Changes in Plasma Levels of Fasting Carnitine.
Fasting plasma levels of carnitine from samples obtained at baseline and at day 28 were compared.
Time frame: Baseline, Day 28
Changes in Plasma Levels of Fasting Betaine.
Fasting plasma levels of betaine from samples obtained at baseline and at day 28 were compared.
Time frame: Baseline, Day 28
Changes in Lipid Profile, Total Cholesterol
Changes in total cholesterol levels between baseline and Day 28
Time frame: Baseline, Day 28
Changes in Lipid Profile, HDL
Changes in measured HDL levels between baseline and Day 28
Time frame: Baseline, Day 28
Changes in Lipid Profile, LDL
Changes in measured LDL levels between baseline and Day 28
Time frame: Baseline, Day 28
Changes in Lipid Profile, Triglycerides
Changes in measured triglyceride levels between baseline and Day 28
Time frame: Baseline, Day 28
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.